SkylineDx: SkylineDx: Independent European data on CP-GEP model in Stratifying Melanoma Patients for Long Term Survival
ROTTERDAM, Netherlands and SAN DIEGO, April 5, 2024 /PRNewswire/ -- SkylineDx is pleased to announce two forthcoming scientific publications at the European Association for Dermato-Oncology congre...
Read full article »
SkylineDx is a biotechnology company that provides gene signature-based diagnostic testing services for cancer.
Read more